BioAge Labs, Inc.
BIOA
$10.18
$0.9610.41%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 5.92M | 3.86M | 1.45M | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.92M | 3.86M | 1.45M | -- | -- |
| Cost of Revenue | 49.47M | 50.97M | 41.60M | 39.81M | 39.81M |
| Gross Profit | -43.55M | -47.11M | -40.15M | -39.81M | -39.81M |
| SG&A Expenses | 26.95M | 25.00M | 22.45M | 19.16M | 16.54M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 95.64M | 95.19M | 83.28M | 78.19M | 66.43M |
| Operating Income | -89.72M | -91.33M | -81.83M | -78.19M | -66.43M |
| Income Before Tax | -75.79M | -79.03M | -71.05M | -71.11M | -70.94M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -75.79 | -79.03 | -71.05 | -71.11 | -70.94 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -75.79M | -79.03M | -71.05M | -71.11M | -70.94M |
| EBIT | -89.72M | -91.33M | -81.83M | -78.19M | -66.43M |
| EBITDA | -89.53M | -91.15M | -81.66M | -78.03M | -66.27M |
| EPS Basic | -2.11 | -8.25 | -15.58 | -22.99 | -34.93 |
| Normalized Basic EPS | -1.32 | -5.16 | -9.74 | -14.27 | -17.97 |
| EPS Diluted | -2.11 | -8.25 | -15.58 | -22.99 | -34.93 |
| Normalized Diluted EPS | -1.32 | -5.16 | -9.74 | -14.27 | -17.97 |
| Average Basic Shares Outstanding | 143.56M | 111.21M | 77.07M | 42.89M | 8.55M |
| Average Diluted Shares Outstanding | 143.56M | 111.21M | 77.07M | 42.89M | 8.55M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |